Clinical trials

  • OFATUMUMAB for Multiple sclerosis | Relapsing-remitting multiple sclerosis
  • TOCILIZUMAB for Behçet's disease-associated uveitis|Behçet's disease
  • RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A; RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, STABILIZED PREFUSION F PROTEIN 847B for Allogeneic hematopoietic stem cell transplantation
  • Lamivudine for HIV infection
  • PARAFFIN WHITE SOFT for Atopic dermatitis
  • Solriamfetol for Idiopathic hypersomnia
  • Bevacizumab for Metastatic colorectal cancer
  • lactose monohydrate for Peripheral arterial disease (PAD)
  • Dry extract from Psilocybe cubensis (15-25:1), extraction solvent: methanol for Depression | Major depressive disorder (moderate-severe)
  • BLEOMYCIN for Cutaneous or subcutaneous malignancy
  • Allogeneic faecal microbiota for Recurrent pouchitis | Ulcerative colitis with ileal-pouch-anal anastomosis (IPAA)
  • Cannabidiol for Glioblastoma